John Loper
Wednesday, May 3, 2017
Small but Promising Signal for Add-on Evinacumab in HoFH
Updated data suggest an add-on contribution of evinacumab over that of current lipid-lowering therapies in the treatment of homozygous familial hypercholesterolemia.
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment